Doping scandal: WADA's path-breaking agreement with GSK

A historic long-term agreement between World Anti-Doping Agency (WADA) and GlaxoSmithKline (GSK), one of the world's leading research-based pharmaceutical and healthcare companies will help future athletes a great deal. Under the agreement, GSK will help WADA create early detection methods for medicines that have performance-enhancing potential in sport.